DropXcell Information

DropXcell enables founders and pre-seed biotech companies to generate high-quality lead molecules without raising institutional capital upfront. Our platform allows us to rapidly design and affordably quantify 10,000x more antibody candidates, dramatically reducing discovery risk early. We partner with early biotechs through low upfront fees and milestone- and royalty-based economics, aligning incentives and preserving founder ownership.